Key points
Affiliates
Michael Benatar [1], Stephen A Goutman [2], Kim A Staats [3], Eva L Feldman [2], Marc Weisskopf [4], Evelyn Talbott [5], Kuldip D Dave [6], Neil M Thakur [6], Ammar Al-Chalabi [7]
- Department of Neurology, University of Miami Miller School of Medicine, Miami, FL, USA
- Neurology, University of Michigan, Ann Arbor, Michigan, USA
- Staats Life Sciences Consulting, Los Angeles, California, USA
- Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA
- Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania, USA
- ALS Association, Washington, District of Columbia, USA
- Department of Basic and Clinical Neuroscience, Maurice Wohl Clinical Neuroscience Institute, King's College London, London, UK
Summary
This paper lays out a prescriptive roadmap for ASL prevention research. The paper identifies a select number of potential high-risk groups to be prioritized in such research. These groups include: People with genetic risk factors, people with mild motor impairment, relatives of people with ALS or other neurological diseases, people who have already developed frontotemporal dementia, veterans, and people with exposures to environmental risks. The paper additionally identifies a list of priorities to facilitate ALS prevention research.
This page was last updated on this date. Updates may include minor edits, image changes, or other modifications to page content.
The information on this page was last reviewed by subject matter experts to ensure accuracy.